NCT07674979Enrolling by invitation
Cardiometabolic Impact of a Produce Prescription Program in Patients With Type 2 Diabetes and Food Insecurity
A Randomized Crossover Trial Evaluating the Cardiometabolic Impact of a Produce Prescription Program in Patients With Type 2 Diabetes and Food Insecurity
Source: ClinicalTrials.gov · Last updated 17 Aug 2026
Brief summary (registry, in English)
This study is testing whether providing monthly vouchers to buy fruits and vegetables can help improve blood sugar control in adults with type 2 diabetes. People receiving care at WVU clinics who recently had an HbA1c level above 8% will be invited to participate in the study. Those who are interested will speak with a study coordinator, be screened for eligibility, and, if eligible, will provide written consent to join the study. Participants will be randomly assigned to one of two groups. One group will receive $100 per month in produce-only grocery vouchers and standardized dietary education for 5 months, followed by 5 months of usual diabetes care. The second group will receive usual diabetes care first for 5 months, followed by 5 months of produce-only grocery vouchers and standardized dietary education. This crossover design allows all participants to experience both approaches during the study. Researchers will measure changes in blood sugar (HbA1c) as the main outcome. Other outcomes include blood pressure, cholesterol levels, body weight, diet quality, food security, anxiety symptoms, depressive symptoms, and physical activity. These will be assessed through lab tests, clinic measurements, and surveys at certain time points during the 10 month study period. The study team will also track how often participants use the vouchers and any challenges they face. The risks of participating are expected to be minimal and similar to routine diabetes care. The total study duration, including enrollment, participation, and analysis, is expected to be about 18 months.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 88 (estimated)
- First submitted
- 24 Jun 2026
- Start date
- Sept 2026
- Primary completion date
- Jun 2027
- Lead sponsor
- West Virginia University
- Diseases
- Type 2 diabetes
- NCT number
- NCT07674979
What you commit to
- Study type: Interventional
- Planned participants: 88
- From Sept 2026 to the primary completion date, Jun 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- End-stage renal disease
- Advanced heart failure
- Severe cognitive impairment
- Pancreatic malignancy
Other
- Chronic pancreatitis
- Pregnancy at time of enrollment
- Anticipated inability to utilize intervention vouchers (e.g., lack of access to Walmart)
Who the study is looking for
- Diagnosis of type 2 diabetes mellitus
- Most recent HbA1c \>8% within the prior 6 months
- Must have had a clinic visit within the past 6 months
- Positive screening for food insecurity based on the USDA 6-item food security survey
- Receiving care through WVU cardiometabolic, endocrinology, or primary care clinics
- Able and willing to provide written informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| West Virginia University Heart and Vascular Institute Coordinator of this site? Confirm its status | Morgantown | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.